Answer
Adults receiving regorafenib (Stivarga) monotherapy for hepatocellular carcinoma must have previously been treated with sorafenib.
Sources for this answer
- Stivarga 40 mg film coated tabletsBayer plc · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked